RxDoctor Payments Data

Mirna Demirdjian, MD

Obstetrics & Gynecology · Mesa, AZNPI 1407085665

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $378 of the $478 with a category attached, or 79.1%. It is spread thinly across 11 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $208 and has fallen 85.5% since, to $30 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in AZ, where the typical reported total is $619.

$478in general payments, 2019–2025

Across 19 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$100
  • Hologic Sales And Service, LLC$86
  • AbbVie$79
  • Shield Therapeutics Inc$45
  • Roche Diagnostics Corporation$43
  • Lilly USA, LLC$30
  • plus $94 from 5 others

What the payments were for

  • Food & beverage$37879%
  • Education$10021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$478 in reported general payments places this provider in the 45th percentile of 757 obstetrics & gynecology providers in Arizona.

See all obstetrics & gynecology providers in Arizona →

Medicare billing

Part B allowed, 2024
$4,481
Medicare patients
14
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Glipizide13$100

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Mesa

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →